Which patient has an indication for antiobesity medication?

Which patient has an indication for antiobesity medication?

• A. BMI 28 with no weight-related comorbidities
• B. BMI 26 with sleep apnea
• C. BMI 25 with hyperlipidemia
• D. BMI 27 with hypertension

Answer: (D)

In obesity treatment, medications are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity. The patient with a BMI of 27 and hypertension fits both parts: there is a weight-related condition (hypertension) and the BMI meets the 27 threshold, so pharmacotherapy is indicated as an adjunct to lifestyle changes. The other scenarios don’t meet both criteria: a BMI of 28 with no comorbidities lacks the weight-related condition, a BMI of 26 with sleep apnea has the comorbidity but a BMI below 27, and a BMI of 25 with hyperlipidemia has a comorbidity but a BMI below 27.

In obesity treatment, medications are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity. The patient with a BMI of 27 and hypertension fits both parts: there is a weight-related condition (hypertension) and the BMI meets the 27 threshold, so pharmacotherapy is indicated as an adjunct to lifestyle changes. The other scenarios don’t meet both criteria: a BMI of 28 with no comorbidities lacks the weight-related condition, a BMI of 26 with sleep apnea has the comorbidity but a BMI below 27, and a BMI of 25 with hyperlipidemia has a comorbidity but a BMI below 27.